RSS Parrot

Study shows semaglutide, tirzepatide and dulaglutide have similar gastrointestinal safety profiles in clinical settings

https://medicalxpress.com/news/2025-11-semaglutide-tirzepatide-dulaglutide-similar-gastrointestinal.html

Published: November 3, 2025 17:00

A new observational study compared the risk for severe gastrointestinal adverse events across dulaglutide, semaglutide, and tirzepatide in patients with type 2 diabetes (T2D). The study found that the medications have similar gastrointestinal safety…

Kimberly-Clark to buy Tylenol owner Kenvue in $48.7 bn deal

https://medicalxpress.com/news/2025-11-kimberly-clark-buy-tylenol-owner.html

Published: November 3, 2025 09:40

US consumer goods giant Kimberly-Clark announced Monday a $48.7 billion deal to acquire the major health company Kenvue, whose Tylenol painkiller has faced Trump administration allegations of links to increased autism risks.

Can a weight loss and diabetes drug treat long COVID?

https://medicalxpress.com/news/2025-10-weight-loss-diabetes-drug-covid.html

Published: November 2, 2025 10:10

Scripps Research in La Jolla announce a new clinical trial that will assess the effectiveness of using drugs approved for diabetes treatment and weight loss to treat long COVID-19, the debilitating chronic condition diagnosed in an estimated 20 million…

FDA to ease copycat drug rules, speeding access to cheaper drugs

https://medicalxpress.com/news/2025-10-fda-ease-copycat-drug-access.html

Published: November 1, 2025 15:00

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to cheaper alternatives.

Q&A: The economic forces that drive prescription drug prices

https://medicalxpress.com/news/2025-10-qa-economic-prescription-drug-prices.html

Published: October 31, 2025 19:00

Luca Maini, assistant professor of health care policy in the Blavatnik Institute at Harvard Medical School, studies competition and regulation in pharmaceutical markets.

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

https://medicalxpress.com/news/2025-10-fda-drug-makers-recalled-blood.html

Published: October 31, 2025 05:50

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.

Women folk healers were branded as witches, but their treatments may have been medically sound

https://medicalxpress.com/news/2025-10-women-folk-healers-branded-witches.html

Published: October 30, 2025 19:30

"Double double toil and trouble" is a quote from Shakespeare's Macbeth that conjures images of evil witches making potions in giant cauldrons. But the truth was that women persecuted as witches were probably legitimate healers of the time.

Experimental cancer drug shows exceptional tumor-fighting potential

https://medicalxpress.com/news/2025-10-experimental-cancer-drug-exceptional-tumor.html

Published: October 30, 2025 15:10

A research team has developed a new chemotherapeutic agent, LiPyDau, which shows remarkable efficacy against multiple tumor types in preclinical studies. Published in the journal Molecular Cancer, the study introduces a highly promising strategy for…

Atorvastatin recall may affect hundreds of thousands of patients, and reflects FDA's troubles

https://medicalxpress.com/news/2025-10-atorvastatin-recall-affect-hundreds-thousands.html

Published: October 30, 2025 12:54

If you take cholesterol-lowering drugs called statins, you may have noticed a flurry of news coverage since late October 2025 about an extensive recall of thousands of bottles of atorvastatin, the generic version of Lipitor.

From antibiotics to antimalarials: How repurposed drugs might keep cancer from returning

https://medicalxpress.com/news/2025-10-antibiotics-antimalarials-repurposed-drugs-cancer.html

Published: October 30, 2025 10:20

Many cancer survivors live with the worry that their cancer might come back. This "recurrence" occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, sometimes years later. Scientists have been trying to…

Antidepressants improve core depressive symptoms early on, analysis finds

https://medicalxpress.com/news/2025-10-antidepressants-core-depressive-symptoms-early.html

Published: October 30, 2025 06:00

One of the most common antidepressants, sertraline, contributes to a modest improvement in core depression and anxiety symptoms, including low mood, within two weeks, finds a new analysis of a major clinical trial led by UCL researchers.

GLP-1 drugs effective for weight loss, but more independent studies needed

https://medicalxpress.com/news/2025-10-glp-drugs-effective-weight-loss.html

Published: October 29, 2025 21:00

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the…

Antibiotics linked to lower risk of complications after obstetric tear

https://medicalxpress.com/news/2025-10-antibiotics-linked-complications-obstetric.html

Published: October 29, 2025 18:30

Giving antibiotics to women within 24 hours of an obstetric tear during childbirth is associated with a reduced risk of larger/clinically relevant wound complications, find the results of a clinical trial from Denmark published by The BMJ today.

Chemists design candidate drug against diabetes

https://medicalxpress.com/news/2025-10-chemists-candidate-drug-diabetes.html

Published: October 29, 2025 16:30

Researchers from the University at Albany and NYU Grossman School of Medicine have found a way to block a key cellular pathway known to drive chronic inflammation and impaired wound healing in people with diabetes.

US aims to quicken approvals for cheaper versions of complex drugs

https://medicalxpress.com/news/2025-10-aims-quicken-cheaper-versions-complex.html

Published: October 29, 2025 16:10

The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and diabetes.

New imaging technique maps drug movement through skin in minutes

https://medicalxpress.com/news/2025-10-imaging-technique-drug-movement-skin.html

Published: October 29, 2025 13:44

By combining mass spectrometry imaging with an automated analysis tool, researchers from Hebrew University have developed a technique that maps medication distribution across skin layers without dyes or labels. Tested on antifungal treatments, it offers a…

New technology restores chemotherapy effectiveness against resistant cancer cells

https://medicalxpress.com/news/2025-10-technology-chemotherapy-effectiveness-resistant-cancer.html

Published: October 29, 2025 12:15

Scientists from King's College London have successfully applied a new technology that disarms one of the most potent weapons cancer cells use to weaken the effects of chemotherapy drugs.

Q&A: New drug being reviewed by the FDA to treat Parkinson's disease

https://medicalxpress.com/news/2025-10-qa-drug-fda-parkinson-disease.html

Published: October 29, 2025 09:15

The U.S. Food and Drug Administration is reviewing a new Parkinson's disease drug called tavapadon that could give people with the disease more control over their movements.

Home treatment with IV antibiotics could relieve NHS pressure

https://medicalxpress.com/news/2025-10-home-treatment-iv-antibiotics-relieve.html

Published: October 29, 2025 08:37

Treating patients at home with IV antibiotics, rather than in a clinical setting, could halve costs to the NHS and relieve pressure on hospital beds—according to a University of East Anglia study.

FDA approves Tezspire for chronic rhinosinusitis with nasal polyps

https://medicalxpress.com/news/2025-10-fda-tezspire-chronic-rhinosinusitis-nasal.html

Published: October 28, 2025 18:10

The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in adult and pediatric patients ages 12 years and older.

Whole tablets may be safer than crushed ones for patients with poststroke swallowing disorders

https://medicalxpress.com/news/2025-10-tablets-safer-patients-poststroke-swallowing.html

Published: October 28, 2025 15:02

For decades, stroke patients with swallowing difficulties have routinely received crushed tablets to reduce the risk of aspiration. New clinical data now challenge this practice. A study using endoscopic swallowing diagnostics in patients with poststroke…

Drugs approved for treating pain may also reduce bone cancer growth

https://medicalxpress.com/news/2025-10-drugs-pain-bone-cancer-growth.html

Published: October 28, 2025 14:49

Peripheral afferent neurons—nerves that send signals from all areas of the body to the central nervous system (brain and spinal cord)—are known to infiltrate and grow within malignant bone tumors called osteosarcomas, often accompanied by severe pain.

Efforts to promote safer opioid prescribing in Canada appear to be having an effect

https://medicalxpress.com/news/2025-10-efforts-safer-opioid-canada-effect.html

Published: October 27, 2025 00:10

Efforts to promote safer opioid prescribing in Canada appear to be having an effect, as new research in the Canadian Medical Association Journal shows a decrease in opioid dispensing between 2018 and 2022.